Areal bone mineral density in children and adolescents with Marfan syndrome: Evidence of an evolving problem

Giuliana Trifirò, Susan Marelli, Maurizio Viecca, Stefano Mora, Alessandro Pini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Marfan syndrome (MFS), an autosomal dominant disorder of connective tissue, is due to defective fibrillin-1. Defects involve the cardiovascular system, the eye, the lungs, and the skeleton. The aim of the current study was to characterize the bone mineral status in children and adolescents with MFS. We performed an observational cross-sectional study and a longitudinal follow-up of two years.We enrolled 73 young patients with MFS (3-17. years). A subset of 44 patients participated in the longitudinal study. Healthy children were studied as controls for biochemical analyses. Bone mineral density (BMD) was measured at lumbar spine, femoral neck and total femur by dual-energy X-ray absorptiometry. BMD values were expressed as Z-scores adjusted for height using height-for-age Z-scores. BMD measurements corrected for height were significantly lower than reference at all skeletal sites (P <0.0001). Patient on cardiac treatment with losartan had lower BMD measurements corrected for height compared to non-treated patients. Total femur BMD decreased significantly over time (P=0.027). BMD at the other two skeletal sites did not change significantly during follow-up, but remained significantly low compared to reference (P <0.0001). In conclusion, young patients with MFS have markedly low BMD at the lumbar spine and femur, and values show a tendency to decrease over time in the peripheral skeleton. Because increased life expectancy of MFS patients, the reduced BMD during childhood may lead to a low peak bone mass, increasing the fracture risk during adult life.

Original languageEnglish
Pages (from-to)176-180
Number of pages5
JournalBone
Volume73
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Marfan Syndrome
Bone Density
Femur
Skeleton
Spine
Bone and Bones
Losartan
Femur Neck
Photon Absorptiometry
Cardiovascular System
Life Expectancy
Connective Tissue
Minerals
Longitudinal Studies
Cross-Sectional Studies
Lung

Keywords

  • Bone mineral density
  • Children
  • Marfan syndrome

ASJC Scopus subject areas

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology
  • Medicine(all)

Cite this

Areal bone mineral density in children and adolescents with Marfan syndrome : Evidence of an evolving problem. / Trifirò, Giuliana; Marelli, Susan; Viecca, Maurizio; Mora, Stefano; Pini, Alessandro.

In: Bone, Vol. 73, 01.04.2015, p. 176-180.

Research output: Contribution to journalArticle

Trifirò, Giuliana ; Marelli, Susan ; Viecca, Maurizio ; Mora, Stefano ; Pini, Alessandro. / Areal bone mineral density in children and adolescents with Marfan syndrome : Evidence of an evolving problem. In: Bone. 2015 ; Vol. 73. pp. 176-180.
@article{dbec2d48e72d44da9c71912db99ecfa1,
title = "Areal bone mineral density in children and adolescents with Marfan syndrome: Evidence of an evolving problem",
abstract = "Marfan syndrome (MFS), an autosomal dominant disorder of connective tissue, is due to defective fibrillin-1. Defects involve the cardiovascular system, the eye, the lungs, and the skeleton. The aim of the current study was to characterize the bone mineral status in children and adolescents with MFS. We performed an observational cross-sectional study and a longitudinal follow-up of two years.We enrolled 73 young patients with MFS (3-17. years). A subset of 44 patients participated in the longitudinal study. Healthy children were studied as controls for biochemical analyses. Bone mineral density (BMD) was measured at lumbar spine, femoral neck and total femur by dual-energy X-ray absorptiometry. BMD values were expressed as Z-scores adjusted for height using height-for-age Z-scores. BMD measurements corrected for height were significantly lower than reference at all skeletal sites (P <0.0001). Patient on cardiac treatment with losartan had lower BMD measurements corrected for height compared to non-treated patients. Total femur BMD decreased significantly over time (P=0.027). BMD at the other two skeletal sites did not change significantly during follow-up, but remained significantly low compared to reference (P <0.0001). In conclusion, young patients with MFS have markedly low BMD at the lumbar spine and femur, and values show a tendency to decrease over time in the peripheral skeleton. Because increased life expectancy of MFS patients, the reduced BMD during childhood may lead to a low peak bone mass, increasing the fracture risk during adult life.",
keywords = "Bone mineral density, Children, Marfan syndrome",
author = "Giuliana Trifir{\`o} and Susan Marelli and Maurizio Viecca and Stefano Mora and Alessandro Pini",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.bone.2014.12.006",
language = "English",
volume = "73",
pages = "176--180",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Areal bone mineral density in children and adolescents with Marfan syndrome

T2 - Evidence of an evolving problem

AU - Trifirò, Giuliana

AU - Marelli, Susan

AU - Viecca, Maurizio

AU - Mora, Stefano

AU - Pini, Alessandro

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Marfan syndrome (MFS), an autosomal dominant disorder of connective tissue, is due to defective fibrillin-1. Defects involve the cardiovascular system, the eye, the lungs, and the skeleton. The aim of the current study was to characterize the bone mineral status in children and adolescents with MFS. We performed an observational cross-sectional study and a longitudinal follow-up of two years.We enrolled 73 young patients with MFS (3-17. years). A subset of 44 patients participated in the longitudinal study. Healthy children were studied as controls for biochemical analyses. Bone mineral density (BMD) was measured at lumbar spine, femoral neck and total femur by dual-energy X-ray absorptiometry. BMD values were expressed as Z-scores adjusted for height using height-for-age Z-scores. BMD measurements corrected for height were significantly lower than reference at all skeletal sites (P <0.0001). Patient on cardiac treatment with losartan had lower BMD measurements corrected for height compared to non-treated patients. Total femur BMD decreased significantly over time (P=0.027). BMD at the other two skeletal sites did not change significantly during follow-up, but remained significantly low compared to reference (P <0.0001). In conclusion, young patients with MFS have markedly low BMD at the lumbar spine and femur, and values show a tendency to decrease over time in the peripheral skeleton. Because increased life expectancy of MFS patients, the reduced BMD during childhood may lead to a low peak bone mass, increasing the fracture risk during adult life.

AB - Marfan syndrome (MFS), an autosomal dominant disorder of connective tissue, is due to defective fibrillin-1. Defects involve the cardiovascular system, the eye, the lungs, and the skeleton. The aim of the current study was to characterize the bone mineral status in children and adolescents with MFS. We performed an observational cross-sectional study and a longitudinal follow-up of two years.We enrolled 73 young patients with MFS (3-17. years). A subset of 44 patients participated in the longitudinal study. Healthy children were studied as controls for biochemical analyses. Bone mineral density (BMD) was measured at lumbar spine, femoral neck and total femur by dual-energy X-ray absorptiometry. BMD values were expressed as Z-scores adjusted for height using height-for-age Z-scores. BMD measurements corrected for height were significantly lower than reference at all skeletal sites (P <0.0001). Patient on cardiac treatment with losartan had lower BMD measurements corrected for height compared to non-treated patients. Total femur BMD decreased significantly over time (P=0.027). BMD at the other two skeletal sites did not change significantly during follow-up, but remained significantly low compared to reference (P <0.0001). In conclusion, young patients with MFS have markedly low BMD at the lumbar spine and femur, and values show a tendency to decrease over time in the peripheral skeleton. Because increased life expectancy of MFS patients, the reduced BMD during childhood may lead to a low peak bone mass, increasing the fracture risk during adult life.

KW - Bone mineral density

KW - Children

KW - Marfan syndrome

UR - http://www.scopus.com/inward/record.url?scp=84920935572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920935572&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2014.12.006

DO - 10.1016/j.bone.2014.12.006

M3 - Article

C2 - 25511867

AN - SCOPUS:84920935572

VL - 73

SP - 176

EP - 180

JO - Bone

JF - Bone

SN - 8756-3282

ER -